Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

RIPK3

RBC: RIPK3 · Substrate: MBP · high confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dabrafenib96.00.63
Cabozantinib94.50.75
Vemurafenib94.50.60
Ibrutinib92.90.72
Dasatinib92.50.70
Regorafenib91.90.72
Lenvatinib90.60.73
Pazopanib82.20.67
Encorafenib76.60.76
Gefitinib71.40.65
Nilotinib65.60.77
Lapatinib52.50.62
Dacomitinib47.40.66
Gilteritinib39.40.51
Vandetanib39.20.72

Known variants

No variants catalogued.
Open in new tab